Siliankang®: Breaking The Intestinal Health Barrier With The Leader Of Clinical Probiotics

May 29, 2025 Leave a message

Industry News

 

Results of the 20th Probiotics and Health Seminar released The seminar held in Beijing from May 19 to 21 released the "Top Ten Landmark Achievements of my country's Probiotics Industry from 2005 to 2025", including milestones such as the establishment of a government-industry-university-research platform and the construction of a bacterial strain resource library. The 11-year follow-up study published by Yakult shows that regular intake of LcS probiotics by the elderly can reduce the risk of hypertension by 26%.

 

Clinical probiotic standards upgraded On World Intestinal Health Day, Yuanda Life Sciences released the "White Paper on the Development of China's Clinical Probiotics Industry", pointing out that 71% of consumers have misunderstandings about strains, and its star product Siliankang® achieves symptom relief within 5 days through a combination of four live bacteria.

 

The market size of hundreds of billions of yuan is expected to exceed US$77 billion in 2025, with China accounting for 25%. Juneyao Health and other companies have achieved a 139% performance growth through the research and development of local strains, breaking the monopoly of international giants.

 

Scientific Guide to Consumption

 

Strain Selection
It is necessary to identify specific strains that have been clinically verified (such as Lactobacillus rhamnosus GG strain). The efficacy of ordinary lactic acid bacteria and probiotics is significantly different. The latest "Probiotic Food" group standard requires products to indicate the strain number and clinical trial basis.

 

Applicable scenarios
Elderly health: Daily intake of fermented dairy products containing LcS can improve bowel movement frequency
Child care: Lactobacillus reuteri DSM17938 is effective for infant colic
Immune regulation: Multi-strain compound products account for more than 60% of the market

Technological breakthroughs


Domestic strains have achieved three major innovations:
① Gastric acid and bile resistance technology (survival rate increased to 90%)
② Hundreds of billions of live bacteria freeze-drying process (applied by brands such as JIU Xiaobao)
③ Targeted delivery system (increase in intestinal colonization rate)

Send Inquiry

whatsapp

teams

VK

Inquiry